Literature DB >> 33878341

A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension.

Anna R Hemnes1, Luke G Silverman-Lloyd2, Shi Huang3, Grant MacKinnon4, Jeffrey Annis5, Carolyn S Whitmore5, Ravinder Mallugari5, Rashundra N Oggs5, Rezzan Hekmat5, Rongzi Shan6, Pauline P Huynh6, Chang Yu3, Seth S Martin6, Michael J Blaha6, Evan L Brittain7.   

Abstract

BACKGROUND: Supervised exercise training improves outcomes in patients with pulmonary arterial hypertension (PAH). The effect of an unsupervised activity intervention has not been tested. RESEARCH QUESTION: Can a text-based mobile health intervention increase step counts in patients with PAH? STUDY DESIGN AND METHODS: We performed a randomized, parallel arm, single-blind clinical trial. We randomized patients to usual care or a text message-based intervention for 12 weeks. The intervention arm received three automated text messages per day with real-time step count updates and encouraging messages rooted in behavioral change theory. Individual step targets increased by 20% every 4 weeks. The primary end point was mean week 12 step counts. Secondary end points included the 6-min walk test, quality of life, right ventricular function, and body composition.
RESULTS: Among 42 randomized participants, the change in raw steps between baseline and week 12 was higher in the intervention group (1,409 steps [interquartile range, -32 to 2,220] vs -149 steps [interquartile range, -1,010 to 735]; P = .02), which persisted after adjustment for age, sex, baseline step counts, and functional class (model estimated difference, 1,250 steps; P = .03). The intervention arm took a higher average number of steps on all days between days 9 and 84 (P < .05, all days). There was no difference in week 12 six-minute walk distance. Analysis of secondary end points suggested improvements in the emPHasis-10 score (adjusted change, -4.2; P = .046), a reduction in visceral fat volume (adjusted change, -170 mL; P = .023), and nearly significant improvement in tricuspid annular plane systolic excursion (model estimated difference, 1.2 mm; P = .051).
INTERPRETATION: This study demonstrated the feasibility of an automated text message-based intervention to increase physical activity in patients with PAH. Additional studies are warranted to examine the effect of the intervention on clinical outcomes. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No. NCT03069716; URL: www.clinicaltrials.gov.
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  clinical trial; exercise; mobile health technology; pulmonary arterial hypertension

Mesh:

Year:  2021        PMID: 33878341      PMCID: PMC8449004          DOI: 10.1016/j.chest.2021.04.012

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   10.262


  21 in total

Review 1.  Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis.

Authors:  Ambarish Pandey; Sushil Garg; Monica Khunger; Sonia Garg; Dharam J Kumbhani; Kelly M Chin; Jarett D Berry
Journal:  Circ Heart Fail       Date:  2015-07-16       Impact factor: 8.790

2.  Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension.

Authors:  Benjamin D Fox; Michael Kassirer; Israela Weiss; Yael Raviv; Nir Peled; David Shitrit; Mordechai R Kramer
Journal:  J Card Fail       Date:  2010-12-03       Impact factor: 5.712

3.  Measurement of quality of life in pulmonary hypertension and its significance.

Authors:  E Cenedese; R Speich; L Dorschner; S Ulrich; M Maggiorini; R Jenni; M Fischler
Journal:  Eur Respir J       Date:  2006-05-17       Impact factor: 16.671

4.  Concurrent Validity of Wearable Activity Trackers Under Free-Living Conditions.

Authors:  Skyler M Brooke; Hyun-Sung An; Seoung-Ki Kang; John M Noble; Kris E Berg; Jung-Min Lee
Journal:  J Strength Cond Res       Date:  2017-04       Impact factor: 3.775

5.  Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension.

Authors:  Leighton Chan; Lisa M K Chin; Michelle Kennedy; Joshua G Woolstenhulme; Steven D Nathan; Ali A Weinstein; Gerilynn Connors; Nargues A Weir; Bart Drinkard; James Lamberti; Randall E Keyser
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

6.  Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.

Authors:  Stephen C Mathai; Tomeka Suber; Rubina M Khair; Todd M Kolb; Rachel L Damico; Paul M Hassoun
Journal:  Ann Am Thorac Soc       Date:  2016-01

7.  Association of Step Volume and Intensity With All-Cause Mortality in Older Women.

Authors:  I-Min Lee; Eric J Shiroma; Masamitsu Kamada; David R Bassett; Charles E Matthews; Julie E Buring
Journal:  JAMA Intern Med       Date:  2019-08-01       Impact factor: 21.873

8.  Validity Evaluation of the Fitbit Charge2 and the Garmin vivosmart HR+ in Free-Living Environments in an Older Adult Cohort.

Authors:  Salvatore Tedesco; Marco Sica; Andrea Ancillao; Suzanne Timmons; John Barton; Brendan O'Flynn
Journal:  JMIR Mhealth Uhealth       Date:  2019-06-19       Impact factor: 4.773

9.  Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.

Authors:  Nicola Ehlken; Mona Lichtblau; Hans Klose; Johannes Weidenhammer; Christine Fischer; Robert Nechwatal; Sören Uiker; Michael Halank; Karen Olsson; Werner Seeger; Henning Gall; Stephan Rosenkranz; Heinrike Wilkens; Dirk Mertens; Hans-Jürgen Seyfarth; Christian Opitz; Silvia Ulrich; Benjamin Egenlauf; Ekkehard Grünig
Journal:  Eur Heart J       Date:  2015-07-31       Impact factor: 29.983

10.  mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion.

Authors:  Seth S Martin; David I Feldman; Roger S Blumenthal; Steven R Jones; Wendy S Post; Rebeccah A McKibben; Erin D Michos; Chiadi E Ndumele; Elizabeth V Ratchford; Josef Coresh; Michael J Blaha
Journal:  J Am Heart Assoc       Date:  2015-11-09       Impact factor: 5.501

View more
  1 in total

1.  Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors.

Authors:  Maria Wieteska-Miłek; Sebastian Szmit; Michał Florczyk; Anna Witowicz; Marcin Kurzyna
Journal:  Int J Environ Res Public Health       Date:  2022-07-08       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.